Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

IDT Earnings: Why IDT Stock Is Soaring 41% After FQ4 Results

By William White, InvestorPlace Writer
IDT (IDT) earnings for the telecommunications company's fiscal fourth quarter of 2020 have its stock soaring higher on Friday.

Hertz Is Taking Shareholders Down a Dead-End Road

By Larry Sullivan, InvestorPlace contributor
It’s been a terrible summer for holders of HTZ stock. The company is in bankruptcy and there’s no good reason to own any of its shares.

Don’t Count Out Inovio Pharmaceuticals Stock Just Yet

By Ian Cooper, InvestorPlace Contributor
INO stock is now a blood-in-the-street opportunity as Inovio is currently facing a temporary hurdle from the FDA.

XTNT Stock Skyrockets After Xtant Medical Holdings Restructures Debt

By Nick Clarkson, Web Editor
Xtant Medical Holdings news on Friday has XTNT stock skyrocketing after the company announced the completion of its debt restructuring plan.

iBio Will Survive Coronavirus Vaccine Disappointment, But It’s not a ‘Buy’

By Todd Shriber, InvestorPlace Contributor
Investors pondering how a company with a history of moving back-and-forth between micro- and small-cap territory could adequately compete against more well-heeled rivals were right to express those concerns and IBIO stock validated those worries.

iBio Is a Pure Spec Play That Remains a Day Trader’s Delight

By Faizan Farooque, InvestorPlace Contributor
IBIO stock will continue to ebb and flow as the pandemic rages on. Day traders should look out for positive clinical trial news as a buy-in signal.

Why Facebook Probably Won’t Outperform the Market

By Larry Ramer, InvestorPlace Contributor
Facebook stock probably won't outperform the market going forward because the company is facing so many tough threats.

Don’t Buy the Dip: Alteryx Stock Is in Real Trouble Now

By Ian Bezek, InvestorPlace Contributor
Many analysts are bullish on AYX stock after the company's terrible Q2 earnings. But risk is elevated, as Alteryx's growth story has serious doubts.

Should You Buy Nvidia Stock? 3 Pros, 3 Cons

By Bret Kenwell, InvestorPlace Contributor
Nvidia has M&A prowess, secular growth and strong technicals. But not everything is perfect with NVDA stock and there are risks. Let's look.

Selling VMware Would Be Big For Dell Stock

By Dana Blankenhorn, InvestorPlace Contributor
Dell stock is currently even more undervalued than IBM, but a spin-off of VMware and some layoffs could cure that problem.

The Real Value in Novavax Goes Beyond the Coronavirus

By Chris Markoch, InvestorPlace Contributor
NVAX stock is up over 2,000% on hopes it will deliver a vaccine for the novel coronavirus. However, the real value comes from its influenza vaccine.

No, Advanced Micro Devices Stock Is Not Too Expensive

By InvestorPlace Research Staff
After a staggering rally from 2016 lows, AMD stock might look expensive. But that's not the right way to look at the situation.

LONE Stock: Why Lonestar Is Soaring 100%

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
Lonestar just received approval to access its cash collateral during bankruptcy, and LONE stock is soaring on the news.

Sorrento Therapeutics Is Simply Running Out of Time

By Chris Markoch, InvestorPlace Contributor
SRNE stock is up over 200% because the company is taking several bites at the Covid-19 apple. However time is not on the company's side.

JFrog Stock Will Be a Buy — But Not Just Yet

By InvestorPlace Research Staff
FROG stock has one of the better stories in software. But with a nearly 100% pop after its IPO, long-term investors should let the stock settle.

Trump Coronavirus News: Why the Market Is Sliding Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
The market is sliding on today on Trump coronavirus news following confirmation that President Donald Trump tested positive.

Did Seattle’s Move on the Hourly Wage Make Lyft Uninvestable?

By Will Ashworth, InvestorPlace Contributor
Seattle passed a minimum hourly wage of $16.39 for Lyft drivers. If you own Lyft stock get used to this kind of thing happening worldwide. 

5 Stocks to Play the Upcoming Election

By Chris Markoch, InvestorPlace Contributor
Investors trying to pick election stocks should look at names that are likely to perform well no matter who occupies 1600 Pennsylvania Avenue.

3 Restaurant Stocks That Coronavirus Hit Hard

By Muslim Farooque, InvestorPlace Contributor
These three restaurant stocks have struggled to improvise amid Covid-19 and the strategic shift toward off-premises sales.
Load More Articles